| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.15 | 0.001 |